… Several therapeutic agents have been developed inhibiting the cytokine itself, the signaling
… in COVID-19 patients [80]. Blockage of this growth factor may halt immunopathology caused …

… To date, no vaccines or effective drugs have been approved to prevent or treat COVID-19 …
and therapeutic drugs. In this regard, treatments addressing the immunopathology of SARS-…

… Nevertheless, these initial reports, along with the previous findings on SARS-CoV, are
the basis behind exploring the therapeutic efficacy of IFN treatment for COVID-19 patients. …

… as IL-6 is crucial in the immunopathogenesis of COVID-19. Produced IL-6 and macrophage
… It has also been extensively studied as a possible therapeutic agent for the regulation of the …

… α for treating COVID-19-related infections to manage COVID-19 and improve … therapeutic
agents are available. However, some supportive therapeutic interventions and anti-viral agents …

… related to Coronavirus-2 (SARS-CoV-2), coronavirus disease-2019 (COVID-19) may cause
… be considered as a potential therapeutic target against severe COVID-19. The relationship …

… Harnessing the immune system to overcome cytokine storm and reduce viral load in covid-19:
a review of the phases of illness and therapeutic agents. Virol J 2020; 17: 1-18. https://doi.…

… on immunopathogenesis of COVID-19 and link that with the various therapeutic approaches
… article, we discuss in brief the basic immunology pertinent to the pathogenesis of COVID-19. …

… development of therapeutic agents is to design drug products to manage COVID-19 efficiently.
… The immunopathogenesis of COVID-19 is summarized in Figure 4; for more information …

… , and the factors affecting the immunopathology of COVID-19 and immune response against
the … that can be harnessed in developing effective therapeutic regimens against COVID-19. …